Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.22.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]    
Revenues $ 0 $ 0
Operating expenses 837,000 1,468,000
Research and development expenses 350,000 355,000
Loss from operations (1,187,000) (1,823,000)
Interest and financing expense (233,000) (592,000)
Net Loss $ (1,420,000) $ (2,415,000)
Net loss per common share, basic and diluted $ (0.00) $ (0.01)
Weighted average common shares outstanding, basic and diluted 336,041,213 316,461,135